Home > Boards > Free Zone > User's Groups > Long Term Investment, Biotech & High Yield Dividend Stocks

<u>SNMX $0.71 &gt;&gt;&gt;&gt; Financial Results: SNMX MY NEXT</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
l2 hunter Member Profile
Member Level 
Followed By 3,959
Posts 152,014
Boards Moderated 2
Alias Born 02/21/11
160x600 placeholder
l2 hunter Member Level  Monday, 10/09/17 06:18:03 AM
Re: None
Post # of 10223 
SNMX $0.71 >>>> Financial Results: SNMX MY NEXT 1000% TURN AROUND TICKET

Commercial revenues increased 24% to $2.8 million in the second quarter ended June 30, 2017. For the six months ended June 30, 2017, commercial revenues increased 25% to $5.5 million. These improvements primarily resulted from higher direct sales of flavor ingredients to flavor houses and higher royalties from sweet taste boosting ingredients


Financial Outlook:

Senomyx ended the second quarter 2017 with no debt and $11.2 million in cash, an increase of $1.1 million during the second quarter. In addition, the Company is scheduled to receive $14.0 million in committed development funding in the future.
For the third quarter of 2017, the Company expects:
Revenues to be at least $4.7 million, of which at least $2.9 million are commercial revenues; and
Net loss not to exceed $3.2 million or $0.07 per share





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist